HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The posttherapy survival of patients with invasive cancer of the vulva].

Abstract
The treatment results and five-years survival are studied in 157 patients with invasive vulvar cancer treated for the period of 1979-1988 in Gynaecological Clinic of the National Oncological Center Institute in Sofia. The general five years survival is 59.2%. The highest is the survival of the patients with first clinical stage--79.55%. The best treatment results are by patients treated with radical vulvectomy and regional lymph node dissection, without histological founded metastases in the extirpated lymph nodes--69.24% five years survival. The authors show some better results because of the better early diagnosis of the disease and the improved therapeutical methods.
AuthorsA Karag'ozov, N Vasilev, Ts Diankova, S Ivanov
JournalAkusherstvo i ginekologiia (Akush Ginekol (Sofiia)) Vol. 31 Issue 2 Pg. 29-31 ( 1992) ISSN: 0324-0959 [Print] Bulgaria
Vernacular TitlePostterapevtichna prezhiviaemost na bolni ot invaziven rak na vulvata.
PMID1342553 (Publication Type: English Abstract, Journal Article)
Topics
  • Bulgaria (epidemiology)
  • Carcinoma (mortality, pathology, therapy)
  • Combined Modality Therapy
  • Female
  • Humans
  • Lymph Node Excision
  • Neoplasm Staging
  • Vulva (surgery)
  • Vulvar Neoplasms (mortality, pathology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: